Evidence map›Paper›PMID 21713119›Full record

ArticleFrontiers in microbiology2010

Characterization of natural killer cells in tamarins: a technical basis for studies of innate immunity.

Tomoyuki Yoshida, Akatsuki Saito, Yuki Iwasaki, Sayuki Iijima, Terue Kurosawa, Yuko Katakai, Yasuhiro Yasutomi, Keith A Reimann, Toshiyuki Hayakawa, Hirofumi Akari

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. A method for expansion of T cells from cynomolgus monkey (Macaca fascicularis).In vitro cellular & developmental biology. Animal · 2018
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Tomoyuki YoshidaTsukuba Primate Research Center, National Institute of Biomedical Innovation Tsukuba, Ibaraki, Japan.
Akatsuki Saito
Yuki Iwasaki
Sayuki Iijima
Terue Kurosawa
Yuko Katakai
Yasuhiro Yasutomi
Keith A Reimann
Toshiyuki Hayakawa
Hirofumi Akari
National Institute of Biomedical Innovation, Health and Nutrition · JPKyoto University · JPCorporation for Production and Research of Laboratory Primates · JPHarvard University · US

Funding

RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIESR24RR016001 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI REIMANN, KEITH A. · 2000 to 2011
$8.1M
Resource for Nonhuman Primate Cell Depleting AntibodiesR24OD010976 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ENGELMAN, KATHLEEN, MAGNANI, DIOGO · 2012 to 2019
$4.7M
NCRR NIH HHS R24 RR016001NIAID NIH HHS HHSN272200900037CNIH HHS R24 OD010976
6 · The paper itself

Abstract

Natural killer (NK) cells are capable of regulating viral infection without major histocompatibility complex restriction. Hepatitis C is caused by chronic infection with hepatitis C virus (HCV), and impaired activity of NK cells may contribute to the control of the disease progression, although the involvement of NK cells in vivo remains to be proven. GB virus B (GBV-B), which is genetically most closely related to HCV, induces acute and chronic hepatitis upon experimental infection of tamarins. This non-human primate model seems likely to be useful for unveiling the roles of NK cells in vivo. Here we characterized the biological phenotypes of NK cells in tamarins and found that depletion of the CD16+ subset in vivo by administration of a monoclonal antibody significantly reduced the number and activity of NK cells.

Indexed as

CD16cynomolgus monkeyNK celltamarin

Identifiers

PMID21713119
PMCPMC3112332
OpenAlexW1986388073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.